JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
PNBK
Patriot National Bancorp, Inc.
There isn't enough reported data to score PNBK yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PNBK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
PNBK's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like PNBK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PNBK PE Valuation
PNBK has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
PNBK Forward outlook
There aren't enough analyst estimates for PNBK to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the stronger earnings trend. Trailing diluted EPS is up 18% for JPM versus PNBK down 137%.
PNBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$2.70 | +$4.69 |
| Q2 2025 | -$9.45 | -$7.89 |
| Q1 2025 | -$10.16 | -$9.21 |
| Q4 2024 | -$10.03 | -$8.98 |
| Q3 2024 | -$7.39 | -$6.54 |
| Q2 2024 | -$1.56 | -326% |
| Q1 2024 | -$0.95 | -181% |
| Q4 2023 | -$1.05 | -168% |
PNBK lost $2.70 per share over the past year, a smaller loss than the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PNBK on profitability, with a higher operating margin.
PNBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.7M | +131% |
| Q2 2026 | $12M | +94% |
| Q1 2026 | $10.3M | +54% |
| Q4 2025 | $9.5M | +44% |
| Q3 2025 | $7.2M | +1.4% |
| Q2 2025 | $6.2M | -12% |
| Q1 2025 | $6.7M | -13% |
| Q4 2024 | $6.6M | -30% |
PNBK's revenue has grown year over year for five quarters in a row: $17M last quarter, up 131% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.1% | +43 points |
| Q2 2026 | -11% | +70 points |
| Q1 2026 | -17% | +25 points |
| Q4 2025 | -23% | +122 points |
| Q3 2025 | -37% | -4.5 points |
| Q2 2025 | -81% | -25 points |
| Q1 2025 | -42% | -39 points |
| Q4 2024 | -145% | -159 points |
PNBK's operating margin was 6.1% last quarter, up 43 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over PNBK on cash flow, with more consistent year-over-year improvement.
PNBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.6M | -$387K |
| Q2 2026 | -$5.7M | -717% |
| Q1 2026 | -$3.5M | +$2.4M |
| Q4 2025 | -$4.1M | -$1.6M |
| Q3 2025 | -$5.3M | -$2.6M |
| Q2 2025 | $918K | -85% |
| Q1 2025 | -$5.9M | -435% |
| Q4 2024 | -$2.5M | -$2.3M |
PNBK's free cash flow was −$19M over the past year, against −$13M the year before. Free cash flow isn't a meaningful measure for financial services companies like PNBK.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PNBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PNBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +1.6M shares |
| 1 year | +52% | +41M shares |
| 3 years | +2904% | +115M shares |
| 5 years | +2910% | +115M shares |
| Available history | +2937% | +115M shares |
PNBK has 119M diluted shares, up 52% from a year ago.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PNBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2023 | -11.2x | Net Cash |
| Q1 2023 | -5.6x | Net Cash |
| Q4 2022 | 8.5x | High |
| Q3 2022 | -1.3x | Net Cash |
| Q2 2022 | -2.3x | Net Cash |
| Q1 2022 | -3.5x | Net Cash |
| Q4 2021 | 11.3x | High |
| Q3 2021 | -4.9x | Net Cash |
PNBK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like PNBK.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PNBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 11.6 | Oversold |
PNBK's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PNBK PE vs Financial Services Sector
| Metric | PNBK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
PNBK has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over PNBK on trend strength, trading above more of its moving averages.
PNBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.88 | 1.1% below |
| 20 week MA | $1.02 | 15% below |
| 50 week MA | $1.21 | 28% below |
| 100 week MA | $1.50 | 42% below |
| 200 week MA | $3.42 | 75% below |
PNBK is in a downtrend: it's below all five of its weekly moving averages, and 75% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over PNBK on returns for 2026, with the stronger performance.
PNBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.7 | $9.66 | -24% |
| 2021 | $9.66 | $14.9 | +54% |
| 2022 | $14.9 | $10.9 | -27% |
| 2023 | $10.9 | $3.83 | -65% |
| 2024 | $3.83 | $1.94 | -49% |
| 2025 | $1.94 | $1.77 | -8.8% |
| 2026 YTD | $1.77 | $0.87 | -51% |
PNBK has finished four years in a row lower, and it's down 51% so far in 2026.